← SynDRA
WAY-161503
SynDRA canonical compound SYN0087088 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | HTR2C |
|---|
| Mechanism of action | Serotonin receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Serotonin receptor agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALOX15
- HTR2A
- TP53
- TDP1
- MAPT
- MAPK1
- KDM4E
- HTR2B
- HSD17B10
- ALOX15B
- HDAC6
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- VDR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- SCG2HM6F3D
- RefChem:106771
- (Rac)-WAY-161503
- SCHEMBL255572
- orb1708232
- SCHEMBL29391309
- CHEBI:91788
- PHGWDAICBXUJDU-UHFFFAOYSA-N
- BDBM50091822
- MFCD06411596
- AKOS017560564
- HY-103138A
- MS-23847
- CS-0109487
- F97572
- T13332
- L019828
- BRD-A62021152-003-01-8
- BRD-A62021152-003-03-4
- 8,9-dichloro-1,2,3,4,4a,6-hexahydropyrazino[1,2-a]quinoxalin-5-one
- 8,9-Dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-one--hydrogen chloride (1/1)
- MS-33066
- SR-01000597762
- SR-01000597762-1
- YS64BL8YFH
- WAY 161503 hydrochloride, >=98% (HPLC)
- CS-0024597
- HY-103138
- (Rac)-WAY-161503 hydrochloride
- orb1703924
- DB-333806
- AKOS024456792
- SCHEMBL1986324
- WAY 161503 hydrochloride
- C13575
- (Rac)-WAY-161503 (hydrochloride)
- WAY161503 hydrochloride
- T23526
- BLA69522
Look up WAY-161503 in the interactive SynDRA portal →